<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="CYP perpetration risk table as per mechanistic-static modeling"><title>CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table • ddir</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table"><meta property="og:description" content="CYP perpetration risk table as per mechanistic-static modeling"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">ddir</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.14.2</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/load-data.html">Load compound-specific data</a>
  </div>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"></ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>CYP perpetration risk table as per mechanistic-static modeling</h1>
      
      <div class="d-none name"><code>mech_stat_cyp_risk_table.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>CYP perpetration risk table as per mechanistic-static modeling</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">mech_stat_cyp_risk_table</span><span class="op">(</span></span>
<span>  <span class="va">perp</span>,</span>
<span>  <span class="va">cyp_inh</span>,</span>
<span>  <span class="va">cyp_ind</span>,</span>
<span>  cyp_tdi <span class="op">=</span> <span class="cn">NULL</span>,</span>
<span>  include_induction <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  substr <span class="op">=</span> <span class="va">cyp_reference_substrates</span>,</span>
<span>  cyp_kdeg <span class="op">=</span> <span class="va">cyp_turnover</span>,</span>
<span>  na.rm <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  show_dose <span class="op">=</span> <span class="cn">FALSE</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>
    <dl><dt>perp</dt>
<dd><p>The perpetrator object.</p></dd>


<dt>cyp_inh</dt>
<dd><p>CYP inhibition data as data frame. The following fields are
expected:</p><ul><li><p>'name' The name of the perpetrator compound.</p></li>
<li><p>'cyp' The CYP enzyme as (upper case) character.</p></li>
<li><p>'ki' The \(k_i\) in µM as numeric.</p></li>
<li><p>'source' Optional source information as character.</p></li>
</ul></dd>


<dt>cyp_ind</dt>
<dd><p>The CYP induction data as data frame. The following fields
are expected:</p><ul><li><p>'name' The name of the perpetrator compound as character.</p></li>
<li><p>'cyp' The CYP enzyme as (upper case) character.</p></li>
<li><p>'emax' The \(E_{max}\), i.e., the maximum induction effect determined in
vitro as numeric.</p></li>
<li><p>'ec50' The \(EC_{50}\) in µM as numeric.</p></li>
<li><p>'maxc' The maximal concentration in µM tested in the in vitro assay as
numeric.</p></li>
<li><p>'source' Optional source information as character.</p></li>
</ul></dd>


<dt>cyp_tdi</dt>
<dd><p>The CYP TDI data as data frame. The following fields are expected:</p><ul><li><p>'name' The perpetrator compound name as character.</p></li>
<li><p>'cyp' The CYP enzyme as character.</p></li>
<li><p>'ki' The \(K_I\) in µM as numeric.</p></li>
<li><p>'kinact' The \(k_{inact}\) in 1/h as numeric.</p></li>
<li><p>'source' Optional source information as character,</p></li>
</ul></dd>


<dt>include_induction</dt>
<dd><p>Switch to define whether induction effects should be
included in the calculation (C-terms as per the FDA guideline)</p></dd>


<dt>substr</dt>
<dd><p>The CYP probe substrates to be used as data frame, defaults to
<a href="cyp_reference_substrates.html">cyp_reference_substrates</a>. The data frame is expected to have the following
fields:</p><ul><li><p>'cyp' The CYP enzyme as (upper case) character.</p></li>
<li><p>'substrate' The substrate name as character.</p></li>
<li><p>'fgut' The fraction of the drug escaping gut metabolism.</p></li>
<li><p>'fm' The fraction of the drug that undergoes hepatic metabolism.</p></li>
<li><p>'fmcyp' The fraction metabolized by the respective CYP enzyme.</p></li>
</ul></dd>


<dt>cyp_kdeg</dt>
<dd><p>The CYP turnover data as data frame. Defaults to the
built-in reference data, <a href="cyp_turnover.html">cyp_turnover</a>.</p></dd>


<dt>na.rm</dt>
<dd><p>Switch to define whether rows with lacking \(K_I\) or
\(k_{deg}\) data are removed from the output.</p></dd>


<dt>show_dose</dt>
<dd><p>Show perpetrator dose in table title, defaults to <code>FALSE.</code></p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    

<p>A markdown-formatted table.</p>
    </div>
    <div class="section level2">
    <h2 id="see-also">See also<a class="anchor" aria-label="anchor" href="#see-also"></a></h2>
    <div class="dont-index"><p><code><a href="mech_stat_cyp_risk.html">mech_stat_cyp_risk()</a></code></p>
<p><a href="cyp_reference_substrates.html">cyp_reference_substrates</a></p></div>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu">mech_stat_cyp_risk_table</span><span class="op">(</span></span></span>
<span class="r-in"><span>  <span class="va">examplinib_parent</span>,</span></span>
<span class="r-in"><span>  <span class="va">examplinib_cyp_inhibition_data</span>,</span></span>
<span class="r-in"><span>  <span class="va">examplinib_cyp_induction_data</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Table: Mechanistic static modeling of the CYP inhibition risk for examplinib</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP     | $K_{i,u}$|substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$|$A_g$ |$A_h$ |$B_g$ |$B_h$ |$C_g$ |$C_h$ |AUCR  |risk  |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |:-------|---------:|:-----------|---------:|-----:|-----------:|:-----|:-----|:-----|:-----|:-----|:-----|:-----|:-----|</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP1A2  |        NA|tizanidine  |      1.00|  0.95|        0.98|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2B6  |        NA|NA          |        NA|    NA|          NA|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |NA    |NA    |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C8  |      11.0|repaglinide |      1.00|  1.00|        0.61|0.626 |0.983 |1.000 |1.000 |1.000 |1.000 |1.011 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C9  |      13.5|S-warfarin  |      1.00|  1.00|        0.91|0.672 |0.986 |1.000 |1.000 |1.000 |1.000 |1.013 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C19 |      15.0|omeprazole  |      1.00|  1.00|        0.87|0.695 |0.987 |1.000 |1.000 |1.000 |1.000 |1.011 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2D6  |        NA|NA          |        NA|    NA|          NA|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |NA    |NA    |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP3A4  |      12.5|midazolam   |      0.57|  0.96|        1.00|0.655 |0.985 |1.000 |1.000 |6.885 |1.774 |0.232 |TRUE  |</span>
<span class="r-in"><span><span class="fu">mech_stat_cyp_risk_table</span><span class="op">(</span></span></span>
<span class="r-in"><span>  <span class="va">examplinib_compounds</span>,</span></span>
<span class="r-in"><span>  <span class="va">examplinib_cyp_inhibition_data</span>,</span></span>
<span class="r-in"><span>  <span class="va">examplinib_cyp_induction_data</span>,</span></span>
<span class="r-in"><span>  <span class="va">examplinib_cyp_tdi_data</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Table: Mechanistic static modeling of the CYP inhibition risk for examplinib</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP     | $K_{i,u}$|substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$|$A_g$ |$A_h$ |$B_g$ |$B_h$ |$C_g$ |$C_h$ |AUCR  |risk  |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |:-------|---------:|:-----------|---------:|-----:|-----------:|:-----|:-----|:-----|:-----|:-----|:-----|:-----|:-----|</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP1A2  |        NA|tizanidine  |      1.00|  0.95|        0.98|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2B6  |        NA|NA          |        NA|    NA|          NA|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |NA    |NA    |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C8  |      11.0|repaglinide |      1.00|  1.00|        0.61|0.626 |0.983 |1.000 |1.000 |1.000 |1.000 |1.011 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C9  |      13.5|S-warfarin  |      1.00|  1.00|        0.91|0.672 |0.986 |1.000 |1.000 |1.000 |1.000 |1.013 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C19 |      15.0|omeprazole  |      1.00|  1.00|        0.87|0.695 |0.987 |1.000 |1.000 |1.000 |1.000 |1.011 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2D6  |        NA|NA          |        NA|    NA|          NA|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |NA    |NA    |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP3A4  |      12.5|midazolam   |      0.57|  0.96|        1.00|0.655 |0.985 |0.435 |0.476 |6.885 |1.774 |0.845 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Table: Mechanistic static modeling of the CYP inhibition risk for M1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP    | $K_{i,u}$|substrate  | $F_{gut}$| $f_m$| $f_{m,CYP}$|$A_g$ |$A_h$ |$B_g$ |$B_h$ |$C_g$ |$C_h$ |AUCR |risk  |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |:------|---------:|:----------|---------:|-----:|-----------:|:-----|:-----|:-----|:-----|:-----|:-----|:----|:-----|</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C9 |       4.4|S-warfarin |         1|     1|        0.91|0.994 |0.994 |1.000 |1.000 |1.000 |1.000 |1.01 |FALSE |</span>
<span class="r-in"><span><span class="fu">mech_stat_cyp_risk_table</span><span class="op">(</span></span></span>
<span class="r-in"><span>  <span class="va">examplinib_compounds</span>,</span></span>
<span class="r-in"><span>  <span class="va">examplinib_cyp_inhibition_data</span>,</span></span>
<span class="r-in"><span>  <span class="va">examplinib_cyp_induction_data</span>,</span></span>
<span class="r-in"><span>  <span class="va">examplinib_cyp_tdi_data</span>, show_dose <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Table: Mechanistic static modeling of the CYP inhibition risk for examplinib (450 mg)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP     | $K_{i,u}$|substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$|$A_g$ |$A_h$ |$B_g$ |$B_h$ |$C_g$ |$C_h$ |AUCR  |risk  |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |:-------|---------:|:-----------|---------:|-----:|-----------:|:-----|:-----|:-----|:-----|:-----|:-----|:-----|:-----|</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP1A2  |        NA|tizanidine  |      1.00|  0.95|        0.98|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2B6  |        NA|NA          |        NA|    NA|          NA|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |NA    |NA    |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C8  |      11.0|repaglinide |      1.00|  1.00|        0.61|0.626 |0.983 |1.000 |1.000 |1.000 |1.000 |1.011 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C9  |      13.5|S-warfarin  |      1.00|  1.00|        0.91|0.672 |0.986 |1.000 |1.000 |1.000 |1.000 |1.013 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C19 |      15.0|omeprazole  |      1.00|  1.00|        0.87|0.695 |0.987 |1.000 |1.000 |1.000 |1.000 |1.011 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2D6  |        NA|NA          |        NA|    NA|          NA|1.000 |1.000 |1.000 |1.000 |1.000 |1.000 |NA    |NA    |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP3A4  |      12.5|midazolam   |      0.57|  0.96|        1.00|0.655 |0.985 |0.435 |0.476 |6.885 |1.774 |0.845 |FALSE |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Table: Mechanistic static modeling of the CYP inhibition risk for M1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP    | $K_{i,u}$|substrate  | $F_{gut}$| $f_m$| $f_{m,CYP}$|$A_g$ |$A_h$ |$B_g$ |$B_h$ |$C_g$ |$C_h$ |AUCR |risk  |</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |:------|---------:|:----------|---------:|-----:|-----------:|:-----|:-----|:-----|:-----|:-----|:-----|:----|:-----|</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> |CYP2C9 |       4.4|S-warfarin |         1|     1|        0.91|0.994 |0.994 |1.000 |1.000 |1.000 |1.000 |1.01 |FALSE |</span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Rainer Strotmann.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer></div>

  

  

  </body></html>

